Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha1 H101R) with a diazepam-insensitive alpha1 subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, α 1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [23]
Citations
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Essential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719
Self-citationType I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Laurie, D., Seeburg, P., & Wisden, W. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01063.1992 · Cited by 667
Research works printed but not linked: 2
- Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
- Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Cited by
Items 201–300 of 1,000
GABAA Receptor α2/α3 Subtype-Selective Modulators as Potential Nonsedating Anxiolytics
Atack, J. R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_30 · Cited by 86
Self-citationGriebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Depoortere, H., Françon, D., Avenet, P., Schoemaker, H., Evanno, Y., et al. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00241.x · Cited by 76
Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation
Pinna, G., Agis-Balboa, R. C., Zhubi, A., Matsumoto, K., Grayson, D. R., Costa, E., & Guidotti, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600329103 · Cited by 79
de Haas, S. L., de Visser, S. J., van der Post, J. P., de Smet, M., Schoemaker, R. C., Rijnbeek, B., Cohen, A. F., Vega, J. M., Agrawal, N. G. B., Goel, T. V., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106072343 · Cited by 84
Munro, G., Ahring, P. K., & Mirza, N. R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.004 · Cited by 84
Cooper, S. J. (2005) · Appetite · doi:10.1016/j.appet.2005.01.003 · Cited by 84
Selleri, S., Bruni, F., Costagli, C., Costanzo, A., Guerrini, G., Ciciani, G., Gratteri, P., Besnard, F., Costa, B., Montali, M., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058002n · Cited by 84
Foster, K. L., McKay, P. F., Seyoum, R., Milbourne, D., Yin, W., Sarma, P., Cook, J. M., & June, H. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300306 · Cited by 84
Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials
Braat, S., & Kooy, R. F. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.028 · Cited by 83
You, I., Jung, Y., Kim, M., Kwon, S., Hong, S., Lee, S., & Jang, C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.013 · Cited by 82
Cremer, C. M., Palomero‐Gallagher, N., Bidmon, H. J., Schleicher, A., Speckmann, E. ‐., & Zilles, K. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.068 · Cited by 82
Anxiety at the Frontier of Molecular Medicine
Weinberger, D. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441612 · Cited by 82
The GABAAReceptor α1Subtype in the Ventral Pallidum Regulates Alcohol-Seeking Behaviors
Harvey, S. C., Foster, K. L., McKay, P. F., Carroll, M. R., Seyoum, R., Woods, J. E., Grey, C., Jones, C. M., McCane, S., Cummings, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03765.2002 · Cited by 77
Pharmacology of Injectable Anesthetics, Sedatives, and Tranquilizers
Meyer, R. E., & Fish, R. E. (2008) · Elsevier eBooks · doi:10.1016/b978-012373898-1.50006-1 · Cited by 81
GABAA receptor subtype selectivity underlying selective anxiolytic effect of baicalin
Wang, F., Xu, Z., Ren, L., Tsang, S. Y., & Xue, H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.040 · Cited by 81
Use of Non-Benzodiazepine Hypnotics in the Elderly: Are All Agents the Same?
Dolder, C. R., Nelson, M., & McKinsey, J. (2007) · CNS Drugs · doi:10.2165/00023210-200721050-00003 · Cited by 82
Transgenic Expression of a Mutant Glycine Receptor Decreases Alcohol Sensitivity of Mice
Findlay, G. S., Wick, M. J., Mascia, M. P., Wallace, D., Miller, G. W., Harris, R. A., & Blednov, Y. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.526 · Cited by 80
GABAA receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone
Ren, L., Wang, F., Xu, Z., Chan, W. M., Zhao, C., & Xue, H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.024 · Cited by 81
Anxiolytics: past, present, and future agents.
Nemeroff, C. B. (2003) · PubMed · Cited by 80
Role of GABAA receptors in cognition
Möhler, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371328 · Cited by 79
Street, L. J., Sternfeld, F., Jelley, R. A., Reeve, A. J., Carling, R. W., Moore, K. W., McKernan, R. M., Sohal, B., Cook, S. M., Pike, A. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0407613 · Cited by 79
Self-citationAnxiety-like behaviour increases safety from fish predation in an amphipod crustacea
Perrot‐Minnot, M., Banchetry, L., & Cézilly, F. (2017) · Royal Society Open Science · doi:10.1098/rsos.171558 · Cited by 80
Taurine modulates the stress response in zebrafish
Mezzomo, N. J., Fontana, B. D., Müller, T. E., Duarte, T., de Quadros, V. A., Canzian, J., Pompermaier, A., Soares, S. M., Koakoski, G., Loro, V. L., et al. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.02.006 · Cited by 79
Enhancing inhibitory synaptic function reverses spatial memory deficits in Shank2 mutant mice
Lim, C., Kim, H., Yu, N., Kang, S. J., Kim, T., Ko, H., Lee, J., Yang, J.-E., Ryu, H.-H., Park, T., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.016 · Cited by 79
Chandra, D., Korpi, E. R., Miralles, C. P., De Blas, A. L., & Homanics, G. E. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-30 · Cited by 69
Lieberman, J. A. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0105 · Cited by 61
Atack, J. R., Maubach, K. A., Wafford, K. A., O'Connor, D. V., Rodrigues, A. D., Evans, D. C., Tattersall, F. D., Chambers, M. S., MacLeod, A. M., Eng, W., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157636 · Cited by 77
Self-citationClayton, T., Chen, J., Ernst, M. C., Richter, L., Cromer, B. A., Morton, C. J., Ng, H. H., Kaczorowski, C. C., Helmstetter, F. J., Furtmüller, R., et al. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782360097 · Cited by 77
Juvenile stress-induced alteration of maturation of the GABAA receptor α subunit in the rat
Jacobson-Pick, S., Elkobi, A., Vander, S., Rosenblum, K., & Richter-Levin, G. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008559 · Cited by 68
Savić, M. M., Huang, S., Furtmüller, R., Clayton, T., Huck, S., Obradovic, D. I., Ugrešić, N. D., Sieghart, W., Bokonjić, D. R., & Cook, J. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301403 · Cited by 78
Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor γ2 subunit
Cope, D. W., Wulff, P., Oberto, A., Aller, M. I., Capogna, M., Ferraguti, F., Halbsguth, C., Hoeger, H., Jolin, H. E., Jones, A., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.03.007 · Cited by 71
Effects of the anesthetic agent propofol on neural populations
Hutt, A., & Longtin, A. (2009) · Cognitive Neurodynamics · doi:10.1007/s11571-009-9092-2 · Cited by 75
The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models
Belzung, C. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00005 · Cited by 75
Tizzano, J. P., Griffey, K. I., & Schoepp, D. D. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00850-x · Cited by 75
Moragues, N., Ciofi, P., Tramu, G., & Garret, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00033-7 · Cited by 75
Girish, C., Raj, V., Arya, J., & Sadasivam, B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.003 · Cited by 74
Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite
Carlson, J. N., Haskew-Layton, R. E., Wacker, J. L., Maisonneuve, I. M., Glick, S. D., & Jerussi, T. P. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00851-2 · Cited by 74
Crestani, F., Assandri, R., Täuber, M., Martin, J. R., & Rudolph, U. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00159-4 · Cited by 73
Jensen, H. S., Nichol, K. E., Lee, D., & Ebert, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088456 · Cited by 72
Russell, M. G. N., Carling, R. W., Atack, J. R., Bromidge, F. A., Cook, S. M., Hunt, P. A., Isted, C., Lucas, M., McKernan, R. M., Mitchinson, A., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040883v · Cited by 72
Self-citationParé, W. P., Tejani‐Butt, S. M., & Kluczynski, J. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00204-4 · Cited by 72
Antidepressant-like effects of kynurenic acid in a modified forced swim test
Tanaka, M., Bohár, Z., Martos, D., Telegdy, G., & Vécsei, L. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00067-5 · Cited by 67
Memory Effects of Benzodiazepines: Memory Stages and Types Versus Binding‐Site Subtypes
Savić, M. M., Obradović, D. I., Ugrešić, N. D., & Bokonjić, D. R. (2005) · Neural Plasticity · doi:10.1155/np.2005.289 · Cited by 64
Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs
Meldrum, B. S. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00066-9 · Cited by 71
Advances in the treatment of anxiety: Targeting glutamate
Simon, A. B., & Gorman, J. M. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.005 · Cited by 70
Rode, F., Jensen, D. G., Blackburn-Munro, G., & Bjerrum, O. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.034 · Cited by 69
Fan, J., Li, D., Chen, H., Huang, J., Xu, J., Zhu, W., Chen, J., & Wang, F. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14519 · Cited by 70
McCool, B. A., Frye, G. D., Pulido, M., & Botting, S. K. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03966-5 · Cited by 69
Christian, E. P., Snyder, D. H., Song, W., Gurley, D. A., Smolka, J., Maier, D. L., Ding, M., Gharahdaghi, F., Liu, X. F., Chopra, M., et al. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00539.2013 · Cited by 68
Lorenzo, L.-É., Godin, A. G., Wang, F., St-Louis, M., Carbonetto, S., Wiseman, P. W., Ribeiro-da-Silva, A., & Koninck, Y. D. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0159-14.2014 · Cited by 68
In Vivo Pharmacological Characterization of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic
Foster, A. C., Pelleymounter, M. A., Cullen, M. J., Lewis, D., Joppa, M. A., Chen, T., Bozigian, H. P., Gross, R. S., & Gogas, K. R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063487 · Cited by 68
Atack, Jr., Hallett, D., Tye, S., Wafford, K., Ryan, C., Sanabria-Bohórquez, S., Eng, W.-S., Gibson, R., Burns, H., Dawson, G., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109354928 · Cited by 63
Self-citationAtor, N. A., Atack, J. R., Hargreaves, R. J., Burns, H. D., & Dawson, G. R. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158303 · Cited by 66
Self-citationCheng, T., Wallace, D. M., Ponteri, B. B., & Tuli, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164307 · Cited by 66
“21,22 L-838,417 has seen popular use in research and is a partial agonist of α 2 , α 3 , and α 5 containing GABA A receptors.”
InfluentialAnxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure
Fischer, B. D., Licata, S. C., Edwankar, R. V., Wang, Z.-J., Huang, S., He, X., Yu, J., Zhou, H., Johnson, E. M., Cook, J. M., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.011 · Cited by 66
Dixon, C. I., Rosahl, T. W., & Stephens, D. N. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.015 · Cited by 66
Self-citationSavić, M. M., Milinković, M. M., Rallapalli, S., Clayton, T., Joksimovic, S. M., Linn, M., & Cook, J. M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000108 · Cited by 66
Nickolls, S. A., Gurrell, R., van Amerongen, G., Kammonen, J., Cao, L., Brown, A. R., Stead, C., Mead, A. N., Watson, C. A., Hsu, C. C., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14119 · Cited by 67
Self-citationAn update on pharmacological approaches to neurodegenerative diseases
Scatena, R., Martorana, G. E., Bottoni, P., Botta, G., Pastore, P., & Giardina, B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.59 · Cited by 66
GABA and its receptors' mechanisms in the treatment of insomnia
Zhu, W., Huang, L., Cheng, H., Li, N., Zhang, B., Dai, W., Wu, X., Zhang, D., Feng, W., Li, S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40665 · Cited by 65
Tapper, E. B., Greeff, Y., & Sengupta, N. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.03.019 · Cited by 65
Atack, Jr., Wafford, K., Street, L., Dawson, G., Tye, S., Van Laere, K., Bormans, G., Sanabria-Bohórquez, S., De Lepeleire, I., de Hoon, J., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109354927 · Cited by 60
Self-citationAsiedu, M. N., Mejia, G. L., Hübner, C. A., Kaila, K., & Price, T. J. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.01.001 · Cited by 65
Early-Life Blockade of 5-HT1A Receptors Alters Adult Anxiety Behavior and Benzodiazepine Sensitivity
Vinkers, C. H., Oosting, R. S., van Bogaert, M. J. V., Olivier, B., & Groenink, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.013 · Cited by 65
Sotiriou, E., Papatheodoropoulos, C., & Angelatou, F. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20670 · Cited by 65
Atack, J. R. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2007.00034.x · Cited by 52
Self-citationResolving differences in GABAA receptor mutant mouse studies
Crestani, F., Martin, J. R., Möhler, H., & Rudolph, U. (2000) · Nature Neuroscience · doi:10.1038/80553 · Cited by 65
Is there a way to curb benzodiazepine addiction?
Lalive, A. L., Rudolph, U., Lüscher, C., & Tan, K. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13277 · Cited by 65
Circuits and components of delta wave regulation
Uygun, D. S., & Basheer, R. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.06.006 · Cited by 64
Layer-Specific Noradrenergic Modulation of Inhibition in Cortical Layer II/III
Salgado, H., Garcia-Oscos, F., Patel, A., Martinolich, L., Nichols, J. A., Dinh, L., Roychowdhury, S., Tseng, K.-Y., & Atzori, M. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq081 · Cited by 58
Takahashi, A., Yap, J. J., Bohager, D. Z., Faccidomo, S., Clayton, T., Cook, J. M., & Miczek, K. A. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1437-8 · Cited by 54
In vitro networks: cortical mechanisms of anaesthetic action
Antkowiak, B. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/aef154 · Cited by 64
Sullivan, S. K., Petroski, R. E., Verge, G. M., Gross, R. S., Foster, A. C., & Grigoriadis, D. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071282 · Cited by 63
Ali, A. B. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00156.2007 · Cited by 62
Olivier, J. D. A., Vinkers, C. H., & Olivier, B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00074 · Cited by 58
Alteration of GABA ergic neurotransmission in Huntington's disease
Garret, M., Du, Z., Chazalon, M., Cho, Y. H., & Baufreton, J. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12826 · Cited by 62
Fradley, R. L., Guscott, M. R., Bull, S., Hallett, D. J., Goodacre, S. C., Wafford, K. A., Garrett, E. M., Newman, R. J., O’Meara, G. F., Whiting, P. J., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106067255 · Cited by 63
Self-citationAnxioselective anxiolytics: can less be more?
Basile, A. S., LIPPA, A. S., & Skolnick, P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.043 · Cited by 62
Sartori, S. B., Hauschild, M., Bunck, M., Gaburro, S., Landgraf, R., & Singewald, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016849 · Cited by 52
Castellano, D., Shepard, R. D., & Lü, W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.616298 · Cited by 61
Khom, S., Strommer, B., Ramharter, J., Schwarz, T., Schwarzer, C., Erker, T., Ecker, G. F., Mulzer, J., & Hering, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00865.x · Cited by 62
Blednov, Y. A., Borghese, C. M., McCracken, M. L., Benavidez, J. M., Geil, C., Osterndorff-Kahanek, E. A., Werner, D. F., Iyer, S. V., Swihart, A., Harrison, N. L., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171645 · Cited by 60
Vinkers, C. H., Klanker, M., Groenink, L., Korte, S. M., Cook, J. M., Linn, M. L. V., Hopkins, S. C., & Olivier, B. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1460-4 · Cited by 62
Chen, X., van Gerven, J., Cohen, A. F., & Jacobs, G. E. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0185-5 · Cited by 60
The promise of new antiepileptic drugs
Duncan, J. S. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01540.x · Cited by 60
Follesa, P., Mancuso, L., Biggio, F., Cagetti, E., Franco, M., TRAPANI, G., & Biggio, G. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00167-8 · Cited by 60
Effects of benzodiazepines receptor agonists on the hypothalamic–pituitary–adrenocortical axis
Mikkelsen, J. D., Søderman, A., Kiss, A., & Mirza, N. R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.049 · Cited by 60
Catatonia and consultation-liaison psychiatry study of 12 cases
Cottencin, O., Warembourg, F., de Lenclave, M. B. D. C., Lucas, B., Vaïva, G., Goudemand, M., & Thomas, P. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.04.006 · Cited by 60
Carling, R. W., Madin, A., Guiblin, A., Russell, M. G. N., Moore, K. W., Mitchinson, A., Sohal, B., Pike, A., Cook, S. M., Ragan, I. C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058034a · Cited by 53
Self-citationAtor, N. A. (2005) · CNS Spectrums · doi:10.1017/s1092852900009883 · Cited by 59
Synaptic modulation in pain pathways
Zeilhofer, H. U. (2005) · Springer eBooks · doi:10.1007/s10254-005-0043-y · Cited by 59
Glycine Receptor Knock-In Mice and Hyperekplexia-Like Phenotypes: Comparisons with the Null Mutant
Findlay, G. S., Phelan, R., Roberts, M. T., Homanics, G. E., Bergeson, S. E., Lopreato, G. F., Mihic, S. J., Blednov, Y. A., & Harris, R. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-22-08051.2003 · Cited by 59
New molecular targets for antianxiety interventions.
Gorman, J. M. (2003) · PubMed · Cited by 59
Diazepam‐induced adaptive plasticity revealed by α1 GABAA receptor‐specific expression profiling
Huopaniemi, L., Keist, R., Randolph, A., Certa, U., & Rudolph, U. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02216.x · Cited by 58
Hagenbuch, N., Feldon, J., & Yee, B. K. (2005) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000189811.77049.3e · Cited by 58
Follesa, P., Cagetti, E., Mancuso, L., Biggio, F., Manca, A., Maciocco, E., Massa, F., Desole, M. S., Carta, M., Busonero, F., et al. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00164-4 · Cited by 58
Genetic manipulations of GABAA receptor in mice make inhibition exciting
Vicini, S., & Ortinski, P. I. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.001 · Cited by 58
Behlke, L. M., Foster, R. A., Liu, J., Benke, D., Benham, R. S., Nathanson, A. J., Yee, B. K., Zeilhofer, H. U., Engin, E., & Rudolph, U. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.49 · Cited by 57
Heldt, S. A., & Ressler, K. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.008 · Cited by 57
Kohtala, S., Theilmann, W., Suomi, T., Wigren, H.-K., Porkka-Heiskanen, T., Elo, L. L., Rokka, A., & Rantamäki, T. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00002 · Cited by 51
Metadata
- Authors
- McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garrett, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K. W., Carling, R. W., Street, L. J., Castro, J. L., Ragan, C. I., Dawson, G. R., & Whiting, P. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- McKernan, R. M.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2000-06
- Volume
- 3
- Issue
- 6
- Pages
- 587-592
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2001619275
- Cited by
- 944
- References
- 35
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 18 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 30 · 2019: 24 · 2018: 37 · 2017: 22 · 2016: 30 · 2015: 29 · 2014: 32 · 2013: 36 · 2012: 37
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, sedation, anxiolytic effects, genetically modified mice, inhibitory neurotransmission, diazepam
- MeSH terms
- Allosteric Site, Animals, Anticonvulsants, Azides, Benzodiazepines, Binding, Competitive, Brain, Cell Line, Diazepam, Dose-Response Relationship, Drug, Flumazenil, Fluorobenzenes, Hypnotics and Sedatives, Ligands, Mice, Inbred C57BL, Mice, Mutant Strains, Motor Activity, Receptors, GABA-A, Reflex, Startle, Anti-Anxiety Agents, Triazoles, Patch-Clamp Techniques, Mice, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.